TerrAscend Corp. ( TSND.TO) - Stock Earnings
TSND.TO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026 BeforeMarket | — / — | — | — / — | — |
TSND.TO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -35.9 million CAD | 90.6 million CAD |
| 2025Q4 | 3.5 million CAD | 92.1 million CAD |
| 2026Q1 | -12.4 million CAD | 89.9 million CAD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TSND.TO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -120.8 million CAD | 420.9 million CAD |
| 2024 | -115.3 million CAD | 440.9 million CAD |
| 2025 | -120.3 million CAD | 363.5 million CAD |
| 2026 Est. | — | — |
TSND.TO
Price: CA$1.04
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.14 CAD
Exchange: TOR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 332.0 million